Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,656 | 21,364 | 62,888 | 66,656 | 34,551 |
| Marketable Securities | 66,294 | 117,643 | 131,951 | 171,301 | 223,818 |
| Receivables | 2,334 | 2,183 | 47,447 | 3,473 | 2,895 |
| Inventories | 158 | 168 | 201 | 231 | 636 |
| TOTAL | $122,527 | $145,084 | $245,806 | $246,193 | $268,606 |
| Non-Current Assets | |||||
| PPE Net | 1,981 | 2,132 | 2,308 | 2,484 | 2,135 |
| Intangibles | 44,543 | 44,543 | 44,543 | 44,543 | 44,543 |
| Other Non-Current Assets | 36,876 | 33,824 | 5,014 | 5,200 | 5,839 |
| TOTAL | $83,400 | $80,499 | $51,865 | $52,227 | $52,517 |
| Total Assets | $205,927 | $225,583 | $297,671 | $298,420 | $321,123 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 42,056 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,797 | 5,899 | 10,689 | 14,801 | 14,201 |
| Accrued Expenses | 13,620 | 11,481 | 12,948 | 30,447 | 21,845 |
| TOTAL | $21,720 | $34,836 | $110,693 | $45,248 | $36,046 |
| Non-Current Liabilities | |||||
| Long Term Debt | 56,508 | 56,107 | 58,643 | 100,298 | 99,895 |
| Deferred Revenues | 4,303 | 17,456 | 45,000 | N/A | N/A |
| Other Non-Current Liabilities | 7,540 | 5,200 | 5,303 | 6,924 | 6,670 |
| TOTAL | $64,048 | $61,307 | $63,946 | $107,222 | $106,565 |
| Total Liabilities | $85,768 | $96,143 | $174,639 | $152,470 | $142,611 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 363,399 | 363,399 | 363,178 | 361,492 | 361,492 |
| Common Shares | 366 | 366 | 366 | 363 | 363 |
| Retained earnings | -2,002,054 | -1,989,285 | -1,992,537 | -1,967,242 | -1,933,476 |
| Other shareholders' equity | -158 | -201 | -162 | 504 | 734 |
| TOTAL | $120,159 | $129,440 | $123,032 | $145,950 | $178,512 |
| Total Liabilities And Equity | $205,927 | $225,583 | $297,671 | $298,420 | $321,123 |